Showing results (1491-1500 of 2,896) with videos related to

Sort By:
Pageof 290
JACC. Cardiovascular Interventions|July 16, 2010
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularizationYoung-Hak Kim, Duk-Woo Park, Won-Jang Kim, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stentingShao-Liang Chen, Jack P Chen, Gary Mintz, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registrySoraya El Ghannudi, Patrick Ohlmann, Nicolas Meyer, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registryTerase Lancefield, David J Clark, Nick Andrianopoulos, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) StudyGiulio Guagliumi, Vasile Sirbu, Hiram Bezerra, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigsMieke van den Heuvel, Oana Sorop, Wendy W Batenburg, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforationRasha Al-Lamee, Alfonso Ielasi, Azeem Latib, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation)Jan Harnek, John G Webb, Karl-Heinz Kuck, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Late restenosis following sirolimus-eluting stent implantationNehiro Kuriyama, Yoshio Kobayashi, Tatsuya Nakama, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsDean J Kereiakes, Krishnankutty Sudhir, James B Hermiller, et al.
Pageof 290